Global Gastrointestinal Stromal Tumor Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gastrointestinal Stromal Tumor Treatment market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gastrointestinal Stromal Tumor Treatment Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumor Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumor Treatment sales for 2023 through 2029. With Gastrointestinal Stromal Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumor Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumor Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumor Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumor Treatment.
United States market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gastrointestinal Stromal Tumor Treatment players cover B. Braun Melsungen, Aohua Endoscopy, Olympus, Novartis, Bayer Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Gastrointestinal Stromal Tumor Treatment market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Gastrointestinal Stromal Tumor Treatment Industry Forecast” looks at past sales and reviews total world Gastrointestinal Stromal Tumor Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Stromal Tumor Treatment sales for 2023 through 2029. With Gastrointestinal Stromal Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Stromal Tumor Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Stromal Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gastrointestinal Stromal Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Stromal Tumor Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Stromal Tumor Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Stromal Tumor Treatment.
United States market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Gastrointestinal Stromal Tumor Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Gastrointestinal Stromal Tumor Treatment players cover B. Braun Melsungen, Aohua Endoscopy, Olympus, Novartis, Bayer Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Drugs
- Surgery Equipment
- Others
- Hospital
- Clinic
- Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Drugs
- Surgery Equipment
- Others
- Hospital
- Clinic
- Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun Melsungen
- Aohua Endoscopy
- Olympus
- Novartis
- Bayer Pharmaceuticals
- Glenmark Pharmaceuticals Ltd.
- Fortimedix Surgical
- Cook Medical
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sonoscape
- Huger endoscopy instruments
- Bulat Pharmaceutical
- MSN Laboratories
- Apotex Inc.
- Boston Scientific
- Arthrex
- Johnson & Johnson
- CSPC Pharmaceuticals
- Hansoh Pharmaceuticals
- Kelun Pharmaceuticals
- Zai Lab
- CStone Pharmaceuticals
- China Biopharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Treatment Market Size 2019-2030
2.1.2 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor Treatment by Country/Region, 2019, 2023 & 2030
2.2 Gastrointestinal Stromal Tumor Treatment Segment by Type
2.2.1 Drugs
2.2.2 Surgery Equipment
2.2.3 Others
2.3 Gastrointestinal Stromal Tumor Treatment Market Size by Type
2.3.1 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumor Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Gastrointestinal Stromal Tumor Treatment Market Size by Application
2.5.1 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL STROMAL TUMOR TREATMENT MARKET SIZE BY PLAYER
3.1 Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Player
3.1.1 Global Gastrointestinal Stromal Tumor Treatment Revenue by Player (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR TREATMENT BY REGION
4.1 Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024)
4.2 Global Gastrointestinal Stromal Tumor Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.4 APAC Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.5 Europe Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.6 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL STROMAL TUMOR TREATMENT MARKET FORECAST
10.1 Global Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.1.1 Global Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.1.2 Americas Gastrointestinal Stromal Tumor Treatment Forecast
10.1.3 APAC Gastrointestinal Stromal Tumor Treatment Forecast
10.1.4 Europe Gastrointestinal Stromal Tumor Treatment Forecast
10.1.5 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Forecast
10.2 Americas Gastrointestinal Stromal Tumor Treatment Forecast by Country (2025-2030)
10.2.1 United States Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.2 Canada Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.3 Mexico Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.4 Brazil Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3 APAC Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Stromal Tumor Treatment Market Forecast
10.3.2 Japan Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.3 Korea Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.4 Southeast Asia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.5 India Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.6 Australia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4 Europe Gastrointestinal Stromal Tumor Treatment Forecast by Country (2025-2030)
10.4.1 Germany Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.2 France Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.3 UK Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.4 Italy Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.5 Russia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.2 South Africa Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.3 Israel Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.4 Turkey Market Gastrointestinal Stromal Tumor Treatment Forecast
10.6 Global Gastrointestinal Stromal Tumor Treatment Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Stromal Tumor Treatment Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Gastrointestinal Stromal Tumor Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 B. Braun Melsungen
11.1.1 B. Braun Melsungen Company Information
11.1.2 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Offered
11.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 B. Braun Melsungen Main Business Overview
11.1.5 B. Braun Melsungen Latest Developments
11.2 Aohua Endoscopy
11.2.1 Aohua Endoscopy Company Information
11.2.2 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Offered
11.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Aohua Endoscopy Main Business Overview
11.2.5 Aohua Endoscopy Latest Developments
11.3 Olympus
11.3.1 Olympus Company Information
11.3.2 Olympus Gastrointestinal Stromal Tumor Treatment Product Offered
11.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Olympus Main Business Overview
11.3.5 Olympus Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gastrointestinal Stromal Tumor Treatment Product Offered
11.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Bayer Pharmaceuticals
11.5.1 Bayer Pharmaceuticals Company Information
11.5.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Pharmaceuticals Main Business Overview
11.5.5 Bayer Pharmaceuticals Latest Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Company Information
11.6.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
11.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
11.6.5 Glenmark Pharmaceuticals Ltd. Latest Developments
11.7 Fortimedix Surgical
11.7.1 Fortimedix Surgical Company Information
11.7.2 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Offered
11.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fortimedix Surgical Main Business Overview
11.7.5 Fortimedix Surgical Latest Developments
11.8 Cook Medical
11.8.1 Cook Medical Company Information
11.8.2 Cook Medical Gastrointestinal Stromal Tumor Treatment Product Offered
11.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cook Medical Main Business Overview
11.8.5 Cook Medical Latest Developments
11.9 Actavis Generics
11.9.1 Actavis Generics Company Information
11.9.2 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Offered
11.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Actavis Generics Main Business Overview
11.9.5 Actavis Generics Latest Developments
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Information
11.10.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
11.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Dr. Reddy's Laboratories Main Business Overview
11.10.5 Dr. Reddy's Laboratories Latest Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Information
11.11.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
11.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.12 Sonoscape
11.12.1 Sonoscape Company Information
11.12.2 Sonoscape Gastrointestinal Stromal Tumor Treatment Product Offered
11.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sonoscape Main Business Overview
11.12.5 Sonoscape Latest Developments
11.13 Huger endoscopy instruments
11.13.1 Huger endoscopy instruments Company Information
11.13.2 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Offered
11.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Huger endoscopy instruments Main Business Overview
11.13.5 Huger endoscopy instruments Latest Developments
11.14 Bulat Pharmaceutical
11.14.1 Bulat Pharmaceutical Company Information
11.14.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Offered
11.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bulat Pharmaceutical Main Business Overview
11.14.5 Bulat Pharmaceutical Latest Developments
11.15 MSN Laboratories
11.15.1 MSN Laboratories Company Information
11.15.2 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
11.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 MSN Laboratories Main Business Overview
11.15.5 MSN Laboratories Latest Developments
11.16 Apotex Inc.
11.16.1 Apotex Inc. Company Information
11.16.2 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Offered
11.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Apotex Inc. Main Business Overview
11.16.5 Apotex Inc. Latest Developments
11.17 Boston Scientific
11.17.1 Boston Scientific Company Information
11.17.2 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Offered
11.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Boston Scientific Main Business Overview
11.17.5 Boston Scientific Latest Developments
11.18 Arthrex
11.18.1 Arthrex Company Information
11.18.2 Arthrex Gastrointestinal Stromal Tumor Treatment Product Offered
11.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Arthrex Main Business Overview
11.18.5 Arthrex Latest Developments
11.19 Johnson & Johnson
11.19.1 Johnson & Johnson Company Information
11.19.2 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product Offered
11.19.3 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Johnson & Johnson Main Business Overview
11.19.5 Johnson & Johnson Latest Developments
11.20 CSPC Pharmaceuticals
11.20.1 CSPC Pharmaceuticals Company Information
11.20.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 CSPC Pharmaceuticals Main Business Overview
11.20.5 CSPC Pharmaceuticals Latest Developments
11.21 Hansoh Pharmaceuticals
11.21.1 Hansoh Pharmaceuticals Company Information
11.21.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Hansoh Pharmaceuticals Main Business Overview
11.21.5 Hansoh Pharmaceuticals Latest Developments
11.22 Kelun Pharmaceuticals
11.22.1 Kelun Pharmaceuticals Company Information
11.22.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Kelun Pharmaceuticals Main Business Overview
11.22.5 Kelun Pharmaceuticals Latest Developments
11.23 Zai Lab
11.23.1 Zai Lab Company Information
11.23.2 Zai Lab Gastrointestinal Stromal Tumor Treatment Product Offered
11.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Zai Lab Main Business Overview
11.23.5 Zai Lab Latest Developments
11.24 CStone Pharmaceuticals
11.24.1 CStone Pharmaceuticals Company Information
11.24.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 CStone Pharmaceuticals Main Business Overview
11.24.5 CStone Pharmaceuticals Latest Developments
11.25 China Biopharmaceuticals
11.25.1 China Biopharmaceuticals Company Information
11.25.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 China Biopharmaceuticals Main Business Overview
11.25.5 China Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
br>
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Treatment Market Size 2019-2030
2.1.2 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor Treatment by Country/Region, 2019, 2023 & 2030
2.2 Gastrointestinal Stromal Tumor Treatment Segment by Type
2.2.1 Drugs
2.2.2 Surgery Equipment
2.2.3 Others
2.3 Gastrointestinal Stromal Tumor Treatment Market Size by Type
2.3.1 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
2.4 Gastrointestinal Stromal Tumor Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Gastrointestinal Stromal Tumor Treatment Market Size by Application
2.5.1 Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
3 GASTROINTESTINAL STROMAL TUMOR TREATMENT MARKET SIZE BY PLAYER
3.1 Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Player
3.1.1 Global Gastrointestinal Stromal Tumor Treatment Revenue by Player (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR TREATMENT BY REGION
4.1 Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024)
4.2 Global Gastrointestinal Stromal Tumor Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.4 APAC Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.5 Europe Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
4.6 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024)
5.2 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
5.3 Americas Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024)
6.2 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
6.3 APAC Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024)
7.2 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
7.3 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment by Region (2019-2024)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL STROMAL TUMOR TREATMENT MARKET FORECAST
10.1 Global Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.1.1 Global Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.1.2 Americas Gastrointestinal Stromal Tumor Treatment Forecast
10.1.3 APAC Gastrointestinal Stromal Tumor Treatment Forecast
10.1.4 Europe Gastrointestinal Stromal Tumor Treatment Forecast
10.1.5 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Forecast
10.2 Americas Gastrointestinal Stromal Tumor Treatment Forecast by Country (2025-2030)
10.2.1 United States Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.2 Canada Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.3 Mexico Market Gastrointestinal Stromal Tumor Treatment Forecast
10.2.4 Brazil Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3 APAC Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.3.1 China Gastrointestinal Stromal Tumor Treatment Market Forecast
10.3.2 Japan Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.3 Korea Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.4 Southeast Asia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.5 India Market Gastrointestinal Stromal Tumor Treatment Forecast
10.3.6 Australia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4 Europe Gastrointestinal Stromal Tumor Treatment Forecast by Country (2025-2030)
10.4.1 Germany Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.2 France Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.3 UK Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.4 Italy Market Gastrointestinal Stromal Tumor Treatment Forecast
10.4.5 Russia Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.2 South Africa Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.3 Israel Market Gastrointestinal Stromal Tumor Treatment Forecast
10.5.4 Turkey Market Gastrointestinal Stromal Tumor Treatment Forecast
10.6 Global Gastrointestinal Stromal Tumor Treatment Forecast by Type (2025-2030)
10.7 Global Gastrointestinal Stromal Tumor Treatment Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Gastrointestinal Stromal Tumor Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 B. Braun Melsungen
11.1.1 B. Braun Melsungen Company Information
11.1.2 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Offered
11.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 B. Braun Melsungen Main Business Overview
11.1.5 B. Braun Melsungen Latest Developments
11.2 Aohua Endoscopy
11.2.1 Aohua Endoscopy Company Information
11.2.2 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Offered
11.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Aohua Endoscopy Main Business Overview
11.2.5 Aohua Endoscopy Latest Developments
11.3 Olympus
11.3.1 Olympus Company Information
11.3.2 Olympus Gastrointestinal Stromal Tumor Treatment Product Offered
11.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Olympus Main Business Overview
11.3.5 Olympus Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Gastrointestinal Stromal Tumor Treatment Product Offered
11.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Bayer Pharmaceuticals
11.5.1 Bayer Pharmaceuticals Company Information
11.5.2 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Pharmaceuticals Main Business Overview
11.5.5 Bayer Pharmaceuticals Latest Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Company Information
11.6.2 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
11.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
11.6.5 Glenmark Pharmaceuticals Ltd. Latest Developments
11.7 Fortimedix Surgical
11.7.1 Fortimedix Surgical Company Information
11.7.2 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Offered
11.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fortimedix Surgical Main Business Overview
11.7.5 Fortimedix Surgical Latest Developments
11.8 Cook Medical
11.8.1 Cook Medical Company Information
11.8.2 Cook Medical Gastrointestinal Stromal Tumor Treatment Product Offered
11.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cook Medical Main Business Overview
11.8.5 Cook Medical Latest Developments
11.9 Actavis Generics
11.9.1 Actavis Generics Company Information
11.9.2 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Offered
11.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Actavis Generics Main Business Overview
11.9.5 Actavis Generics Latest Developments
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Information
11.10.2 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
11.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Dr. Reddy's Laboratories Main Business Overview
11.10.5 Dr. Reddy's Laboratories Latest Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Information
11.11.2 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
11.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.12 Sonoscape
11.12.1 Sonoscape Company Information
11.12.2 Sonoscape Gastrointestinal Stromal Tumor Treatment Product Offered
11.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sonoscape Main Business Overview
11.12.5 Sonoscape Latest Developments
11.13 Huger endoscopy instruments
11.13.1 Huger endoscopy instruments Company Information
11.13.2 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Offered
11.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Huger endoscopy instruments Main Business Overview
11.13.5 Huger endoscopy instruments Latest Developments
11.14 Bulat Pharmaceutical
11.14.1 Bulat Pharmaceutical Company Information
11.14.2 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Offered
11.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bulat Pharmaceutical Main Business Overview
11.14.5 Bulat Pharmaceutical Latest Developments
11.15 MSN Laboratories
11.15.1 MSN Laboratories Company Information
11.15.2 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
11.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 MSN Laboratories Main Business Overview
11.15.5 MSN Laboratories Latest Developments
11.16 Apotex Inc.
11.16.1 Apotex Inc. Company Information
11.16.2 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Offered
11.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Apotex Inc. Main Business Overview
11.16.5 Apotex Inc. Latest Developments
11.17 Boston Scientific
11.17.1 Boston Scientific Company Information
11.17.2 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Offered
11.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Boston Scientific Main Business Overview
11.17.5 Boston Scientific Latest Developments
11.18 Arthrex
11.18.1 Arthrex Company Information
11.18.2 Arthrex Gastrointestinal Stromal Tumor Treatment Product Offered
11.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Arthrex Main Business Overview
11.18.5 Arthrex Latest Developments
11.19 Johnson & Johnson
11.19.1 Johnson & Johnson Company Information
11.19.2 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product Offered
11.19.3 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Johnson & Johnson Main Business Overview
11.19.5 Johnson & Johnson Latest Developments
11.20 CSPC Pharmaceuticals
11.20.1 CSPC Pharmaceuticals Company Information
11.20.2 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 CSPC Pharmaceuticals Main Business Overview
11.20.5 CSPC Pharmaceuticals Latest Developments
11.21 Hansoh Pharmaceuticals
11.21.1 Hansoh Pharmaceuticals Company Information
11.21.2 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Hansoh Pharmaceuticals Main Business Overview
11.21.5 Hansoh Pharmaceuticals Latest Developments
11.22 Kelun Pharmaceuticals
11.22.1 Kelun Pharmaceuticals Company Information
11.22.2 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Kelun Pharmaceuticals Main Business Overview
11.22.5 Kelun Pharmaceuticals Latest Developments
11.23 Zai Lab
11.23.1 Zai Lab Company Information
11.23.2 Zai Lab Gastrointestinal Stromal Tumor Treatment Product Offered
11.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Zai Lab Main Business Overview
11.23.5 Zai Lab Latest Developments
11.24 CStone Pharmaceuticals
11.24.1 CStone Pharmaceuticals Company Information
11.24.2 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 CStone Pharmaceuticals Main Business Overview
11.24.5 CStone Pharmaceuticals Latest Developments
11.25 China Biopharmaceuticals
11.25.1 China Biopharmaceuticals Company Information
11.25.2 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
11.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 China Biopharmaceuticals Main Business Overview
11.25.5 China Biopharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
br>
LIST OF TABLES
Table 1. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Drugs
Table 4. Major Players of Surgery Equipment
Table 5. Major Players of Others
Table 6. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Table 9. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Gastrointestinal Stromal Tumor Treatment Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player (2019-2024)
Table 14. Gastrointestinal Stromal Tumor Treatment Key Players Head office and Products Offered
Table 15. Gastrointestinal Stromal Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Table 20. Global Gastrointestinal Stromal Tumor Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor Treatment
Table 40. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor Treatment
Table 41. Key Industry Trends of Gastrointestinal Stromal Tumor Treatment
Table 42. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. B. Braun Melsungen Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 47. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Offered
Table 48. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. B. Braun Melsungen Main Business
Table 50. B. Braun Melsungen Latest Developments
Table 51. Aohua Endoscopy Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 52. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Offered
Table 53. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Aohua Endoscopy Main Business
Table 55. Aohua Endoscopy Latest Developments
Table 56. Olympus Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 57. Olympus Gastrointestinal Stromal Tumor Treatment Product Offered
Table 58. Olympus Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Olympus Main Business
Table 60. Olympus Latest Developments
Table 61. Novartis Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 62. Novartis Gastrointestinal Stromal Tumor Treatment Product Offered
Table 63. Novartis Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Bayer Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 67. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 68. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Bayer Pharmaceuticals Main Business
Table 70. Bayer Pharmaceuticals Latest Developments
Table 71. Glenmark Pharmaceuticals Ltd. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 72. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 73. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Glenmark Pharmaceuticals Ltd. Main Business
Table 75. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 76. Fortimedix Surgical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 77. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 78. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Fortimedix Surgical Main Business
Table 80. Fortimedix Surgical Latest Developments
Table 81. Cook Medical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 82. Cook Medical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 83. Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Cook Medical Main Business
Table 85. Cook Medical Latest Developments
Table 86. Actavis Generics Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 87. Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Offered
Table 88. Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Actavis Generics Main Business
Table 90. Actavis Generics Latest Developments
Table 91. Dr. Reddy's Laboratories Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 92. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
Table 93. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Dr. Reddy's Laboratories Main Business
Table 95. Dr. Reddy's Laboratories Latest Developments
Table 96. Teva Pharmaceutical Industries Ltd. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 97. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 98. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Teva Pharmaceutical Industries Ltd. Main Business
Table 100. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 101. Sonoscape Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 102. Sonoscape Gastrointestinal Stromal Tumor Treatment Product Offered
Table 103. Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Sonoscape Main Business
Table 105. Sonoscape Latest Developments
Table 106. Huger endoscopy instruments Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 107. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Offered
Table 108. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Huger endoscopy instruments Main Business
Table 110. Huger endoscopy instruments Latest Developments
Table 111. Bulat Pharmaceutical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 112. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 113. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Bulat Pharmaceutical Main Business
Table 115. Bulat Pharmaceutical Latest Developments
Table 116. MSN Laboratories Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 117. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
Table 118. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. MSN Laboratories Main Business
Table 120. MSN Laboratories Latest Developments
Table 121. Apotex Inc. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 122. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 123. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Apotex Inc. Main Business
Table 125. Apotex Inc. Latest Developments
Table 126. Boston Scientific Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 127. Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Offered
Table 128. Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Boston Scientific Main Business
Table 130. Boston Scientific Latest Developments
Table 131. Arthrex Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 132. Arthrex Gastrointestinal Stromal Tumor Treatment Product Offered
Table 133. Arthrex Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Arthrex Main Business
Table 135. Arthrex Latest Developments
Table 136. Johnson & Johnson Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 137. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product Offered
Table 138. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Johnson & Johnson Main Business
Table 140. Johnson & Johnson Latest Developments
Table 141. CSPC Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 142. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 143. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. CSPC Pharmaceuticals Main Business
Table 145. CSPC Pharmaceuticals Latest Developments
Table 146. Hansoh Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 147. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 148. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Hansoh Pharmaceuticals Main Business
Table 150. Hansoh Pharmaceuticals Latest Developments
Table 151. Kelun Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 152. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 153. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Kelun Pharmaceuticals Main Business
Table 155. Kelun Pharmaceuticals Latest Developments
Table 156. Zai Lab Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 157. Zai Lab Gastrointestinal Stromal Tumor Treatment Product Offered
Table 158. Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 159. Zai Lab Main Business
Table 160. Zai Lab Latest Developments
Table 161. CStone Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 162. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 163. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 164. CStone Pharmaceuticals Main Business
Table 165. CStone Pharmaceuticals Latest Developments
Table 166. China Biopharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 167. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 168. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 169. China Biopharmaceuticals Main Business
Table 170. China Biopharmaceuticals Latest Developments
br>
Table 1. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor Treatment Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Drugs
Table 4. Major Players of Surgery Equipment
Table 5. Major Players of Others
Table 6. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Table 9. Gastrointestinal Stromal Tumor Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Gastrointestinal Stromal Tumor Treatment Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player (2019-2024)
Table 14. Gastrointestinal Stromal Tumor Treatment Key Players Head office and Products Offered
Table 15. Gastrointestinal Stromal Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Table 20. Global Gastrointestinal Stromal Tumor Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor Treatment
Table 40. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor Treatment
Table 41. Key Industry Trends of Gastrointestinal Stromal Tumor Treatment
Table 42. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Gastrointestinal Stromal Tumor Treatment Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. B. Braun Melsungen Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 47. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product Offered
Table 48. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. B. Braun Melsungen Main Business
Table 50. B. Braun Melsungen Latest Developments
Table 51. Aohua Endoscopy Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 52. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product Offered
Table 53. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Aohua Endoscopy Main Business
Table 55. Aohua Endoscopy Latest Developments
Table 56. Olympus Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 57. Olympus Gastrointestinal Stromal Tumor Treatment Product Offered
Table 58. Olympus Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Olympus Main Business
Table 60. Olympus Latest Developments
Table 61. Novartis Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 62. Novartis Gastrointestinal Stromal Tumor Treatment Product Offered
Table 63. Novartis Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. Bayer Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 67. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 68. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Bayer Pharmaceuticals Main Business
Table 70. Bayer Pharmaceuticals Latest Developments
Table 71. Glenmark Pharmaceuticals Ltd. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 72. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 73. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Glenmark Pharmaceuticals Ltd. Main Business
Table 75. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 76. Fortimedix Surgical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 77. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 78. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Fortimedix Surgical Main Business
Table 80. Fortimedix Surgical Latest Developments
Table 81. Cook Medical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 82. Cook Medical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 83. Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Cook Medical Main Business
Table 85. Cook Medical Latest Developments
Table 86. Actavis Generics Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 87. Actavis Generics Gastrointestinal Stromal Tumor Treatment Product Offered
Table 88. Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Actavis Generics Main Business
Table 90. Actavis Generics Latest Developments
Table 91. Dr. Reddy's Laboratories Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 92. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
Table 93. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Dr. Reddy's Laboratories Main Business
Table 95. Dr. Reddy's Laboratories Latest Developments
Table 96. Teva Pharmaceutical Industries Ltd. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 97. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 98. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Teva Pharmaceutical Industries Ltd. Main Business
Table 100. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 101. Sonoscape Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 102. Sonoscape Gastrointestinal Stromal Tumor Treatment Product Offered
Table 103. Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Sonoscape Main Business
Table 105. Sonoscape Latest Developments
Table 106. Huger endoscopy instruments Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 107. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product Offered
Table 108. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Huger endoscopy instruments Main Business
Table 110. Huger endoscopy instruments Latest Developments
Table 111. Bulat Pharmaceutical Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 112. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product Offered
Table 113. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Bulat Pharmaceutical Main Business
Table 115. Bulat Pharmaceutical Latest Developments
Table 116. MSN Laboratories Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 117. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product Offered
Table 118. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. MSN Laboratories Main Business
Table 120. MSN Laboratories Latest Developments
Table 121. Apotex Inc. Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 122. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product Offered
Table 123. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Apotex Inc. Main Business
Table 125. Apotex Inc. Latest Developments
Table 126. Boston Scientific Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 127. Boston Scientific Gastrointestinal Stromal Tumor Treatment Product Offered
Table 128. Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Boston Scientific Main Business
Table 130. Boston Scientific Latest Developments
Table 131. Arthrex Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 132. Arthrex Gastrointestinal Stromal Tumor Treatment Product Offered
Table 133. Arthrex Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Arthrex Main Business
Table 135. Arthrex Latest Developments
Table 136. Johnson & Johnson Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 137. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product Offered
Table 138. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Johnson & Johnson Main Business
Table 140. Johnson & Johnson Latest Developments
Table 141. CSPC Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 142. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 143. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. CSPC Pharmaceuticals Main Business
Table 145. CSPC Pharmaceuticals Latest Developments
Table 146. Hansoh Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 147. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 148. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Hansoh Pharmaceuticals Main Business
Table 150. Hansoh Pharmaceuticals Latest Developments
Table 151. Kelun Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 152. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 153. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Kelun Pharmaceuticals Main Business
Table 155. Kelun Pharmaceuticals Latest Developments
Table 156. Zai Lab Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 157. Zai Lab Gastrointestinal Stromal Tumor Treatment Product Offered
Table 158. Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 159. Zai Lab Main Business
Table 160. Zai Lab Latest Developments
Table 161. CStone Pharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 162. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 163. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 164. CStone Pharmaceuticals Main Business
Table 165. CStone Pharmaceuticals Latest Developments
Table 166. China Biopharmaceuticals Details, Company Type, Gastrointestinal Stromal Tumor Treatment Area Served and Its Competitors
Table 167. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product Offered
Table 168. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 169. China Biopharmaceuticals Main Business
Table 170. China Biopharmaceuticals Latest Developments
br>
LIST OF FIGURES
Figure 1. Gastrointestinal Stromal Tumor Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Gastrointestinal Stromal Tumor Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Stromal Tumor Treatment Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Stromal Tumor Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Stromal Tumor Treatment in Hospital
Figure 11. Global Gastrointestinal Stromal Tumor Treatment Market: Hospital (2019-2024) & ($ millions)
Figure 12. Gastrointestinal Stromal Tumor Treatment in Clinic
Figure 13. Global Gastrointestinal Stromal Tumor Treatment Market: Clinic (2019-2024) & ($ millions)
Figure 14. Gastrointestinal Stromal Tumor Treatment in Pharmacy
Figure 15. Global Gastrointestinal Stromal Tumor Treatment Market: Pharmacy (2019-2024) & ($ millions)
Figure 16. Gastrointestinal Stromal Tumor Treatment in Others
Figure 17. Global Gastrointestinal Stromal Tumor Treatment Market: Others (2019-2024) & ($ millions)
Figure 18. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application in 2023
Figure 19. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player in 2023
Figure 20. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Figure 21. Americas Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 22. APAC Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 23. Europe Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 25. Americas Gastrointestinal Stromal Tumor Treatment Value Market Share by Country in 2023
Figure 26. United States Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 32. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 33. China Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 37. India Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 43. France Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 56. APAC Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 57. Europe Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 59. United States Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 60. Canada Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 61. Mexico Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 62. Brazil Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 63. China Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 64. Japan Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 65. Korea Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 67. India Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 68. Australia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 69. Germany Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 70. France Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 71. UK Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 72. Italy Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 73. Russia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 74. Egypt Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 75. South Africa Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 76. Israel Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 77. Turkey Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 79. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Gastrointestinal Stromal Tumor Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Gastrointestinal Stromal Tumor Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastrointestinal Stromal Tumor Treatment Sales Market Share by Country/Region (2023)
Figure 8. Gastrointestinal Stromal Tumor Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type in 2023
Figure 10. Gastrointestinal Stromal Tumor Treatment in Hospital
Figure 11. Global Gastrointestinal Stromal Tumor Treatment Market: Hospital (2019-2024) & ($ millions)
Figure 12. Gastrointestinal Stromal Tumor Treatment in Clinic
Figure 13. Global Gastrointestinal Stromal Tumor Treatment Market: Clinic (2019-2024) & ($ millions)
Figure 14. Gastrointestinal Stromal Tumor Treatment in Pharmacy
Figure 15. Global Gastrointestinal Stromal Tumor Treatment Market: Pharmacy (2019-2024) & ($ millions)
Figure 16. Gastrointestinal Stromal Tumor Treatment in Others
Figure 17. Global Gastrointestinal Stromal Tumor Treatment Market: Others (2019-2024) & ($ millions)
Figure 18. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application in 2023
Figure 19. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Player in 2023
Figure 20. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Figure 21. Americas Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 22. APAC Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 23. Europe Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size 2019-2024 ($ millions)
Figure 25. Americas Gastrointestinal Stromal Tumor Treatment Value Market Share by Country in 2023
Figure 26. United States Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region in 2023
Figure 31. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 32. APAC Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 33. China Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 37. India Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Country in 2023
Figure 40. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 41. Europe Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 42. Germany Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 43. France Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Gastrointestinal Stromal Tumor Treatment Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 56. APAC Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 57. Europe Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 59. United States Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 60. Canada Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 61. Mexico Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 62. Brazil Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 63. China Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 64. Japan Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 65. Korea Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 67. India Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 68. Australia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 69. Germany Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 70. France Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 71. UK Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 72. Italy Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 73. Russia Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 74. Egypt Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 75. South Africa Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 76. Israel Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 77. Turkey Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Gastrointestinal Stromal Tumor Treatment Market Size 2025-2030 ($ millions)
Figure 79. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Gastrointestinal Stromal Tumor Treatment Market Size Market Share Forecast by Application (2025-2030)
